Proactive Investors - Run By Investors For Investors

PotBotics’ unit Ryah Medtech partners with Green Revolution to bring dose-measuring vaporizer to Washington state

The company said the launch in Washington ‘is only the first domino to fall’ as Ryah is finalizing launches in several other states
PotBotics’ unit Ryah Medtech partners with Green Revolution to bring dose-measuring vaporizer to Washington state
The BrainBot enables physicians to pick a marijuana strain that is most suited for their patients' needs

PotBotics Inc’s wholly owned subsidiary Ryah Medtech said Friday that it has entered into a partnership with Green Revolution to launch a portable medicinal dose-measuring vaporizer in the Washington state market.

Washington state legalized medical and recreational marijuana in 2012. The legal age to consume marijuana in Washington is 21.

Ryah Medtech creates smart devices to personalize medication specific to an individual’s needs and operates an artificial intelligence platform that gathers insightful data on cannabis from seed to consumption.

READ: Namaste says it’s scouting for Namaste Café locations in Toronto and Montreal

Green Revolution is a leading producer and processor in Washington State with a track record of creating innovative cannabis-based products.

“This will come as exciting news for a lot of people who have been following Ryah and who were waiting for it to launch in the Pacific Northwest, particularly patients within Washington that are eager to adopt the Ryah dose-measuring vaporizer in order to properly create a cannabis dosing regimen,” said PotBotics CEO David Goldstein.

New York-based Potbotics has three cannabis-related products. It has created a software and technology platform called PotBot that is able to talk to patients and educate them about what strains are actually best for their ailments. It is used in dispensaries and medical facilities where marijuana patients can ask questions and get information. 

The medical marijuana recommendation engine uses neural-net algorithms to recommend cannabinoid levels and custom strains.

Seizing marijuana opportunities

The company also has BrainBot, a wireless electroencephalography helmet that allows general practitioners to capture brain waves and analyze a patient’s neural response to cannabinoid stimulants to recommend the right strain and cannabinoid level. The brain-scanning technology enables physicians to pick a marijuana strain that is most suited for their patients' needs. It also provides NanoPot, an advanced DNA reader that scans cannabis seeds to optimize growers’ yields.

“With consumers increasingly demanding high-quality products that put them in control of their cannabis experience, the timing could not be better for bringing Ryah to the Washington market,” said Leo Shlovksy, managing partner at Green Revolution.

“We intend to come into the market with an initial array of four different cartridges, targeted towards both the medical and wellness market,” said Goldstein, adding that the launch marked “the shift from the development stage to production stage” of its vaporizer. “We are now in full-launch mode in one of the biggest cannabis markets in the US,” he said.

The company said the launch in Washington “is only the first domino to fall” as Ryah is finalizing launches in several other states.

By providing users with unprecedented temperature and dose control, the RYAH medicinal vaporizer delivers consistency.

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full PROAC profile View Profile

Proactiveinvestors Timeline

Related Articles

pills
March 22 2019
The healthcare-focused advisory group boasts good levels of forward bookings thanks to several new business wins at the beginning of 2019
Augmented Reality on phone
March 21 2019
The firm currently has around nine companies in its portfolio that are either direct investments or through its sub-fund, Suir Valley Ventures, in which it holds a 22% stake
Bloomsbury Publishing
March 19 2019
Peel Hunt expects “superior returns" from the firm’s investment in digital capacity
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use